207 related articles for article (PubMed ID: 34016494)
1. Myasthenia gravis with inflammatory myopathy without elevation of creatine kinase.
Kanbayashi T; Tanaka S; Hatanaka Y; Uchio N; Shimizu J; Sonoo M
Neuromuscul Disord; 2021 Jun; 31(6):570-573. PubMed ID: 34016494
[TBL] [Abstract][Full Text] [Related]
2. Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report.
Kamo H; Hatano T; Kanai K; Aoki N; Kamiyama D; Yokoyama K; Takanashi M; Yamashita Y; Shimo Y; Hattori N
BMC Neurol; 2019 Aug; 19(1):184. PubMed ID: 31382909
[TBL] [Abstract][Full Text] [Related]
3. Myasthenia gravis with inclusion body myositis: A case report.
Kakutani T; Yoshizawa M
Mod Rheumatol Case Rep; 2023 Dec; 8(1):83-85. PubMed ID: 37210209
[TBL] [Abstract][Full Text] [Related]
4. [A case of anti-acetylcholine receptor antibody-positive ocular myasthenia gravis with anti-titin antibody and anti-Kv1.4 antibody positive inflammatory myopathy].
Fuse K; Araki A; Morozumi S; Yasui K; Kazuta T; Noda S; Katsuno M
Rinsho Shinkeigaku; 2023 Dec; 63(12):830-835. PubMed ID: 37989286
[TBL] [Abstract][Full Text] [Related]
5. Distal upper limb involvement in myasthenia-myositis association.
Lauletta A; Fionda L; Merlonghi G; Leonardi L; Morino S; Bucci E; Tufano L; Alfieri G; Costanzo R; Rossini E; Salvetti M; Antonini G; Garibaldi M
Neurol Sci; 2023 Feb; 44(2):719-722. PubMed ID: 36336775
[TBL] [Abstract][Full Text] [Related]
6. Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patients.
Garibaldi M; Fionda L; Vanoli F; Leonardi L; Loreti S; Bucci E; Di Pasquale A; Morino S; Vizzaccaro E; Merlonghi G; Ceccanti M; Lucchini M; Mirabella M; Andreetta F; Pennisi EM; Petrucci A; Salvetti M; Antonini G
Autoimmun Rev; 2020 Apr; 19(4):102498. PubMed ID: 32062029
[TBL] [Abstract][Full Text] [Related]
7. A novel case of inclusion body myositis and myasthenia gravis.
Lambrianides S; Kinnis E; Cleanthous M; Papacharalambous R; Panayiotou E; Zamba-Papanicolaou E; Kyriakides T
Neuromuscul Disord; 2019 Oct; 29(10):771-775. PubMed ID: 31604651
[TBL] [Abstract][Full Text] [Related]
8. [Myasthenia Gravis and Myositis(PD-1 Myopathy)].
Suzuki S
Gan To Kagaku Ryoho; 2020 Feb; 47(2):219-223. PubMed ID: 32381950
[TBL] [Abstract][Full Text] [Related]
9. Thymoma may explain the confusion: a case report.
Maaroufi A; Assoufi N; Essaoudi MA; Fatihi J
J Med Case Rep; 2021 Dec; 15(1):616. PubMed ID: 34911585
[TBL] [Abstract][Full Text] [Related]
10. Granulomatous Myositis Associated With Acetylcholine Receptor Antibodies Without Clinical Myasthenia.
Jin J; Isfort MC; Ascherman DP; Lacomis D
J Clin Neuromuscul Dis; 2021 Sep; 23(1):49-52. PubMed ID: 34431802
[TBL] [Abstract][Full Text] [Related]
11. Granulomatous inflammatory myopathy associated with myasthenia gravis. A case report and review of the literature.
Pascuzzi RM; Roos KL; Phillips LH
Arch Neurol; 1986 Jun; 43(6):621-3. PubMed ID: 3718292
[TBL] [Abstract][Full Text] [Related]
12. Marked Respiratory Failure in an Ambulant Patient with Immune-mediated Necrotizing Myopathy and Anti-Kv1.4 and Anti-titin Antibodies.
Sugiyama A; Onishi Y; Ito K; Shibuya K; Nakamura K; Oda F; Nishino I; Suzuki S; Kuwabara S
Intern Med; 2021 Aug; 60(16):2671-2675. PubMed ID: 33642484
[TBL] [Abstract][Full Text] [Related]
13. Myopathy in Childhood Muscle-Specific Kinase Myasthenia Gravis.
Kirzinger L; Khomenko A; Schulte-Mattler W; Backhaus R; Platen S; Schalke B
Pediatr Neurol; 2016 Dec; 65():90-92. PubMed ID: 27697312
[TBL] [Abstract][Full Text] [Related]
14. [An autopsy case of nivolumab-induced myasthenia gravis and myositis].
Sawai T; Hosokawa T; Shigekiyo T; Ogawa S; Sano E; Arawaka S
Rinsho Shinkeigaku; 2019 Jun; 59(6):360-364. PubMed ID: 31142711
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilia, myositis, and myasthenia gravis associated with a thymoma.
Avni I; Sharabi Y; Sadeh M; Buchman AS
Muscle Nerve; 2006 Aug; 34(2):242-5. PubMed ID: 16506154
[TBL] [Abstract][Full Text] [Related]
16. Dermatomyositis and myastenia gravis: An uncommon association with therapeutic implications.
Sangüesa Gómez C; Flores Robles BJ; Méndez Perles C; Barbadillo C; Godoy H; Andréu JL
Reumatol Clin; 2015; 11(4):244-6. PubMed ID: 25498320
[TBL] [Abstract][Full Text] [Related]
17. Two patients with co-morbid myasthenia gravis in a Brazilian cohort of inflammatory bowel disease.
Gondim Fde A; de Oliveira GR; Araújo DF; Souza MH; Braga LL; Thomas FP
Neuromuscul Disord; 2014 Nov; 24(11):999-1002. PubMed ID: 25065584
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy-related skeletal muscle weakness in cancer patients: a case series.
Ng AH; Molinares DM; Ngo-Huang AT; Bruera E
Ann Palliat Med; 2021 Feb; 10(2):2359-2365. PubMed ID: 32575996
[TBL] [Abstract][Full Text] [Related]
19. A case of late-onset, thymoma-associated myasthenia gravis with ryanodine receptor and titin antibodies and concomitant granulomatous myositis.
Stefanou MI; Komorowski L; Kade S; Bornemann A; Ziemann U; Synofzik M
BMC Neurol; 2016 Sep; 16(1):172. PubMed ID: 27623618
[TBL] [Abstract][Full Text] [Related]
20. Neurogenic muscle involvement in myasthenia gravis. A clinical and histopathological study.
Oosterhuis H; Bethlem J
J Neurol Neurosurg Psychiatry; 1973 Apr; 36(2):244-54. PubMed ID: 4708458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
